In this week's Journal, Liu et al. provide some insight on what makes a "reactive" astrocyte reactive. The authors look at activated astrocytes using several models of optic nerve injury. The epidermal growth factor receptor (EGFR) was not...

This week, Osipova et al. made use of the high temporal and spatial resolution of magnetoencephalography (MEG) to examine oscillatory activity associated with a memory task. The authors presented subjects with a series of pictures of build...

The excitatory amino acid transporter 4 (EAAT4) is an unusual beast. Expressed predominantly in cerebellum Purkinje cells rather than glia, the molecule also functions as an anion-selective ion channel. The current model for transport is t...

With the aid of a brain sensor, Matthew Nagle, who is paralysed from the neck down, was able to open an e-mail, pinch the finger of a prosthetic hand and play his way through a computer game - just by using his thoughts. Scientists, from M...

Scientists at Melbourne's Howard Florey Institute have found a protein in the brain that can save neurons from dying after experiencing traumatic brain injury from incidents such as stroke, car accidents and falls. The team, led by Profess...

Boston LifeSciences, Inc. (Nasdaq: BLSI), a biotechnology company focused ondiagnostic and therapeutic products for diseases of the Central NervousSystem (CNS), today announced that it will be presenting at FriedlandInvestment Events East...

Experience, as the old saying goes, is the best teacher. And experience seems to play an important early role in how infants learn to understand and produce language. Using technology that measures the magnetic field generated by the a...

Patients with Parkinson's disease who are undergoing a treatment known as deep brain stimulation may benefit from the direct involvement of a neurologist with expertise both in movement disorders and in deep brain stimulation, according to...

The brain, traffic and nano-circuits -- e-Science takes on major challengesIssued by EPSRC on behalf of the UK e-Science Programme Research into three major scientific and technological challenges is to receive a major boost from the appli...

BioAxone Therapeutic announced todaythat it has completed its targeted patient enrollment of the Phase I/IIaNorth American clinical trial of Cethrin(R) for the treatment of acutespinal cord injury (SCI). Cethrin(R), a recombinant protein-b...